| Product Code: ETC6658528 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada IVD Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada IVD Market Revenues & Volume, 2021 & 2031F |
3.3 Canada IVD Market - Industry Life Cycle |
3.4 Canada IVD Market - Porter's Five Forces |
3.5 Canada IVD Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Canada IVD Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 Canada IVD Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Canada IVD Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Canada IVD Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Canada |
4.2.2 Technological advancements in the field of in vitro diagnostics (IVD) |
4.2.3 Growing demand for personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval |
4.3.2 High cost associated with IVD testing |
4.3.3 Limited reimbursement policies for certain IVD tests |
5 Canada IVD Market Trends |
6 Canada IVD Market, By Types |
6.1 Canada IVD Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Canada IVD Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Canada IVD Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.4 Canada IVD Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 Canada IVD Market Revenues & Volume, By Software And Services, 2021- 2031F |
6.2 Canada IVD Market, By Technique |
6.2.1 Overview and Analysis |
6.2.2 Canada IVD Market Revenues & Volume, By Immunodiagnostics, 2021- 2031F |
6.2.3 Canada IVD Market Revenues & Volume, By Blood Testing, 2021- 2031F |
6.2.4 Canada IVD Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.2.5 Canada IVD Market Revenues & Volume, By Tissue Diagnostics, 2021- 2031F |
6.2.6 Canada IVD Market Revenues & Volume, By Clinical Chemistry, 2021- 2031F |
6.2.7 Canada IVD Market Revenues & Volume, By Other Ivd Techniques, 2021- 2031F |
6.3 Canada IVD Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Canada IVD Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.3 Canada IVD Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Canada IVD Market Revenues & Volume, By Cardiac Diseases, 2021- 2031F |
6.3.5 Canada IVD Market Revenues & Volume, By Immune System Disorders, 2021- 2031F |
6.3.6 Canada IVD Market Revenues & Volume, By Nephrological Diseases, 2021- 2031F |
6.3.7 Canada IVD Market Revenues & Volume, By Gastrointestinal Diseases, 2021- 2031F |
6.4 Canada IVD Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Canada IVD Market Revenues & Volume, By Standalone Laboratories, 2021- 2031F |
6.4.3 Canada IVD Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Canada IVD Market Revenues & Volume, By Academic And Medical Schools, 2021- 2031F |
6.4.5 Canada IVD Market Revenues & Volume, By Point Of Care Testing, 2021- 2031F |
6.4.6 Canada IVD Market Revenues & Volume, By Others End-User, 2021- 2031F |
7 Canada IVD Market Import-Export Trade Statistics |
7.1 Canada IVD Market Export to Major Countries |
7.2 Canada IVD Market Imports from Major Countries |
8 Canada IVD Market Key Performance Indicators |
8.1 Adoption rate of innovative IVD technologies |
8.2 Number of partnerships and collaborations in the IVD market |
8.3 Rate of integration of artificial intelligence and machine learning in IVD solutions |
9 Canada IVD Market - Opportunity Assessment |
9.1 Canada IVD Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Canada IVD Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.3 Canada IVD Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Canada IVD Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Canada IVD Market - Competitive Landscape |
10.1 Canada IVD Market Revenue Share, By Companies, 2024 |
10.2 Canada IVD Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here